🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
184

Quick answer

United Therapeutics Europe has 184 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. MapMySmoke

    United Therapeutics Europe Ltd

    Smoking

    phase 1 other active

    1 trial

  2. Metformin

    United Therapeutics Europe Ltd

    Tendinopathy

    phase 1 small molecule active

    1 trial

  3. Minocycline

    United Therapeutics Europe Ltd

    Alcohol Dependence

    phase 1 small molecule completed

    1 trial

  4. Mirasol System for Whole Blood.

    United Therapeutics Europe Ltd

    Healthy

    phase 1 mab terminated

    1 trial

  5. N-Acetylcysteine

    United Therapeutics Europe Ltd

    Mitochondrial Disease

    phase 1 small molecule active

    1 trial

  6. N-acetylcysteine, NAC, and calcitriol

    United Therapeutics Europe Ltd

    HIE - Perinatal Hypoxic - Ischemic Encephalopathy

    phase 1 small molecule completed

    1 trial

  7. NDV-3 vaccine with alum IM

    United Therapeutics Europe Ltd

    Staphylococcal Infections

    phase 1 mab completed

    1 trial

  8. Nanosensor

    United Therapeutics Europe Ltd

    MItochondrial Myopathies

    phase 1 other active

    1 trial

  9. Nivolumab

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 1 small molecule active

    1 trial

  10. Norovirus

    United Therapeutics Europe Ltd

    Healthy Adults

    phase 1 mab completed

    1 trial

  11. ONX-0801

    United Therapeutics Europe Ltd

    Solid Tumours

    phase 1 small molecule completed

    1 trial

  12. Oxymetazoline

    United Therapeutics Europe Ltd

    Fecal Incontinence

    phase 1 small molecule active

    1 trial

  13. Oxytocin

    United Therapeutics Europe Ltd

    Unit Cohesion

    phase 1 small molecule completed

    1 trial

  14. P3C541b Lipopeptide

    United Therapeutics Europe Ltd

    HIV Infections

    phase 1 mab completed

    1 trial

  15. PLX-PAD

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule terminated

    1 trial

  16. PNT001

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 1 mab terminated

    1 trial

  17. PSA/IL-2/GM-CSF

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 mab active

    1 trial

  18. PVSRIPO

    United Therapeutics Europe Ltd

    Invasive Breast Cancer

    phase 1 mab completed

    1 trial

  19. Palbociclib + Taselisib / Pictilisib

    United Therapeutics Europe Ltd

    Advanced Solid Tumours

    phase 1 small molecule completed

    1 trial

  20. Pembrolizumab

    United Therapeutics Europe Ltd

    Cervix Cancer

    phase 1 other terminated

    1 trial

  21. Pembrolizumab

    United Therapeutics Europe Ltd

    Thoracic Tumours

    phase 1 small molecule completed

    1 trial

  22. Physical Activity Educational Materials

    United Therapeutics Europe Ltd

    Physical Inactivity

    phase 1 other completed

    1 trial

  23. Pitavastatin

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  24. Placebo Intravaginal Ring A

    United Therapeutics Europe Ltd

    Safety

    phase 1 other terminated

    1 trial

  25. Placebo Vaginal Film with Square Corners

    United Therapeutics Europe Ltd

    Safety

    phase 1 small molecule completed

    1 trial

  26. Plasmodium falciparum Malaria Protein 010 (FMP010)

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  27. Plerixafor

    United Therapeutics Europe Ltd

    Pancreatic Adenocarcinoma Metastatic

    phase 1 small molecule completed

    1 trial

  28. Pramipexole

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  29. Protexia

    United Therapeutics Europe Ltd

    Intervention for Nerve Agent Exposure

    phase 1 mab completed

    1 trial

  30. Provision of extra (care coordination and management) services

    United Therapeutics Europe Ltd

    Hospitalization

    phase 1 other completed

    1 trial

  31. Psilocybin

    United Therapeutics Europe Ltd

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule active

    1 trial

  32. Q-Griffithsin

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule completed

    1 trial

  33. Q-Griffithsin 3.0

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule active

    1 trial

  34. Rehabilitation

    United Therapeutics Europe Ltd

    Stroke

    phase 1 other completed

    1 trial

  35. SOM 230 / Pasireotide

    United Therapeutics Europe Ltd

    Atypical Ductal Breast Hyperplasia

    phase 1 small molecule completed

    1 trial

  36. Shigella sonnei 53G

    United Therapeutics Europe Ltd

    Healthy

    phase 1 mab completed

    1 trial

  37. Shigella sonnei 53G

    United Therapeutics Europe Ltd

    Shigellosis

    phase 1 mab active

    2 trials

  38. Simvastatin

    United Therapeutics Europe Ltd

    Recurrent Acute Pancreatitis

    phase 1 small molecule active

    1 trial

  39. TAF/EVG Vaginal Insert

    United Therapeutics Europe Ltd

    Hiv

    phase 1 small molecule completed

    1 trial

  40. TAF/EVG vaginal insert

    United Therapeutics Europe Ltd

    Safety Issues

    phase 1 small molecule completed

    1 trial

  41. Tepotinib

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  42. TransCon PEG treprostinil

    United Therapeutics Europe Ltd

    PAH

    phase 1 small molecule terminated

    1 trial

  43. Treprostinil Inhalation Powder

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule completed

    1 trial

  44. Treprostinil diethanolamine

    United Therapeutics Europe Ltd

    Hypertension, Pulmonary

    phase 1 small molecule completed

    2 trials

  45. UB-221

    United Therapeutics Europe Ltd

    Chronic Idiopathic Urticaria

    phase 1 small molecule active

    1 trial

  46. UB-221

    United Therapeutics Europe Ltd

    Urticaria Chronic

    phase 1 mab completed

    1 trial

  47. UB-421 SC

    United Therapeutics Europe Ltd

    HIV-1-infection

    phase 1 mab active

    1 trial

  48. UB-421 SC(dB4C7C22-6 mAb)

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 1 mab completed

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

184 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.